Refined prediction of week 12 response and SVR based on week 4 response in HCV genotype 1 patients treated with peginterferon alfa-2a (40KD) and ribavirin

  • Patrick Marcellin, Nancy Reau, Peter Ferenci, Stephanos Hadziyannis, Diethelm Messinger, Fernando Tatsch, Donald Jensen
  • Journal of Hepatology, June 2012, Elsevier
  • DOI: 10.1016/j.jhep.2011.12.026

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Peter Ferenci